- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02801214
Emotional Brain Processes in Recreational Cannabis Users
February 1, 2017 updated by: Benjamin Becker, University of Electronic Science and Technology of China
Effects of Recreational Cannabis Use on Brain Activation Patterns Associated With Emotional Processes
This fMRI study investigates neural correlates of emotion regulation, emotion processing and craving in recreational cannabis users.
Study Overview
Study Type
Observational
Enrollment (Anticipated)
50
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 40 years (ADULT)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
Male
Sampling Method
Non-Probability Sample
Study Population
Recreational male cannabis users
Description
Inclusion Criteria:
- Recreational cannabis use
- 72 hours of abstinence
Exclusion Criteria:
- neurological disorders
- psychiatric disorders according to DSM-4
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
---|---|
Recreational Cannabis Use
ages 18-40
|
|
Healthy control subjects
socio-demographically matched
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
fMRI neural correlates of emotional brain processes in recreational cannabis users after 72 hours of abstinence
Time Frame: one time point = fMRI assessment after 72 hours of abstinence
|
Activation patterns in brain regions known to be involved in emotional processing and to be altered by cannabis use (e.g.
striatum, prefrontal cortex, insula, ACC)
|
one time point = fMRI assessment after 72 hours of abstinence
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Ratings of subjective experience (affect, craving)
Time Frame: one time point = during fMRI assessment after 72 hours of abstinence
|
one time point = during fMRI assessment after 72 hours of abstinence
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
May 1, 2015
Primary Completion (ACTUAL)
December 1, 2015
Study Completion (ACTUAL)
December 1, 2016
Study Registration Dates
First Submitted
June 11, 2016
First Submitted That Met QC Criteria
June 11, 2016
First Posted (ESTIMATE)
June 15, 2016
Study Record Updates
Last Update Posted (ESTIMATE)
February 2, 2017
Last Update Submitted That Met QC Criteria
February 1, 2017
Last Verified
February 1, 2017
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- ART_Can_02
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Recreational Cannabis Use
-
Ensysce BiosciencesDr. Vince Clinical ResearchCompletedRecreational Drug UseUnited States
-
Ensysce BiosciencesCompletedRecreational Drug UseUnited States
-
AstraZenecaCompletedRecreational CNS Depressant UseCanada
-
Chinese University of Hong KongRecruiting
-
The University of Tennessee, KnoxvilleColorado State UniversityActive, not recruitingCannabis Use Disorder, Mild | Cannabis Use Disorder, Moderate | Cannabis Use Disorder, SevereUnited States
-
Centre hospitalier de l'Université de Montréal...RecruitingCannabis | Cannabis Dependence | Cannabis Use | Cannabis Smoking | Cannabis Use, UnspecifiedCanada
-
Medical University of South CarolinaNational Institute on Drug Abuse (NIDA)RecruitingCannabis Use Disorder, Mild | Cannabis Use Disorder, Moderate | Cannabis Use Disorder, SevereUnited States
-
Elias DakwarRecruitingAddiction | Cannabis Dependence | Cannabis Use | Substance Abuse | Cannabis Abuse | Cannabis Use DisorderUnited States
-
University of California, San FranciscoNational Institute on Drug Abuse (NIDA); National Institutes of Health (NIH); Food and Drug Administration (FDA)Not yet recruitingTobacco Use | Cannabis | Cannabis Use | Vaping | THC | Cannabis SmokingUnited States
-
Monash UniversityTurning PointCompletedCannabis Use Disorder, Moderate | Cannabis Use Disorder, SevereAustralia
Clinical Trials on fMRI
-
Weill Medical College of Cornell UniversityMemorial Sloan Kettering Cancer CenterWithdrawnBrain TumorsUnited States
-
Centre Hospitalier Universitaire de Saint EtienneUniversity Hospital of Saint-EtienneCompleted
-
Centre Hospitalier Universitaire de Saint EtienneTerminatedMagnetic Resonance Imaging | Neuronal ActivityFrance
-
Brighton & Sussex Medical SchoolRecruitingDepressionUnited Kingdom
-
Van Boven, Robert W., M.D.Massachusetts Institute of Technology; The Geneva FoundationUnknownTraumatic Brain Injury | Post Traumatic Stress DisorderUnited States
-
Hospices Civils de LyonUniversity of KonstanzCompleted
-
Boston VA Research Institute, Inc.Mclean Hospital; Cambridge Health Alliance; Northeastern UniversityRecruitingSchizophrenia | Treatment-resistant Schizophrenia | Auditory HallucinationUnited States